Biology engineering company Evozyne announced this week that Mike Gamson has been named its next CEO. Gamson will lead the company into its next phase and will set commercial direction for Evozyne.
Gamson is well known in Chicago tech circles and has invested in several local startups, including Cameo and ThinkCerca. With years of experience building and transforming tech companies into global market leaders, he will look to build upon Evozyne's early success to foster commercial growth.
Gamson most recently served as CEO of Relativity, a global legal tech company. A LinkedIn veteran, Gamson spent nearly 12 years at the employment-focused social media platform, where he was most recently a senior vice president and led teams across 30 offices worldwide and grew revenue from tens of millions to multiple billions.
Founded in 2020 by Paragon Biosciences, Evozyne develops novel proteins for critical applications in therapeutics and sustainability. Evozyne combines engineering and AI to develop transformative solutions for gene optimization, antibody discovery and gene editing, with the potential to develop applications in sustainability.
